National consensus statement for application of therapeutic plasmapheresis in neurological diseases
2019
Keywords:
apheresis, Therapeutic plasmapheresis, therapeutic plasma exchangeAbstract
Introduction
The term apheresis comes from Greek (ἀφαίρεσις), and literally refers to a "withdraw". Apheresis is a procedure in which blood of the patient or donor is passed through a medical device which separates out one or more components of blood and returns remainder with or without extracorporeal treatment or replacement of the separated component.
According to the American Society for Apheresis (ASFA) therapeutic apheresis procedures included adsorptive cytapheresis, extracorporeal photopheresis, selective filtration, immunoadsorption, LDL apheresis, leukocytapheresis, thrombocytapheresis, red blood cell (RBC) exchange, rheopheresis, plasmapheresis, therapeutic plasma exchange (TPE),
The terms therapeutic plasmapheresis and therapeutic plasma exchange are often used as synonyms in literature, therefore, in the current consensus we have accepted the concept of therapeutic plasmapheresis to be perceived in the sense of therapeutic plasma exchange.
Therapeutic plasmapheresis (therapeutic plasma exchange) is a beneficial aphaeretic method in the treatment of a number of neurological conditions. In some of them its effectiveness was proven, and in others - studies are under way to eventually confirm it.
References
Milanov, I. National Consensus for Diagnosis and Treatment of Multiple Sclerosis. Movement Disorders, 2018, 15, Suppl. 3, 59 pp.
Chifligarov, К., Stefanov, Ch., Pavlov, G., Minev, Iv. Clinical experience in the sustained maintenance of patients with Myasthenia Gravis, achieved by therapeutic plasmaexchange (ТРЕХ). Bulgarian Neurology, 2013, 14, 2, 64-65.
Arnason, B.G., Judith, A., Baumann, R.J., Freedman, S.M., Goldberg, J.D., Hanson, T., Hester, J.P., et al. The Utility of Therapeutic Plasmapheresis for Neurological Disorders. NIH Consens Statement, 1986, 6, 4, 1-7.
Bonnan, M., Cabre, P. Plasma Exchange in Severe Attacks of Neuromyelitis Optica. Multiple Sclerosis International, 2012, Article ID 787630, 9 pages http://dx.doi.org/10.1155/2012/787630
Cortese, I., Chaudhry, V., So, Y.T., Cantor, F., Cornblat, D.R., Rae-Grant, A. Evidence-based guideline update: Plasmapheresis in neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 2011, 76, 294-300.
Dyck, P.J., Daube, J., O’Brien, P., Pineda, A., Low, P.A., Windebank, A.J., Swanson, C. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N. Engl. J. Med., 1986, 314, 461–465.
Gajdos, P., Chevret, S., Toyka, K. Plasma exchange for myasthenia gravis. Cochrane Database Syst. Rev., 2002, 4, CD002275.
Guyatt, G., Gutterman, D., Baumann, M.H., Addrizzo-Harris, D., Hylek, E.M., Phillips, B., Raskob, G., Lewis, S.Z., Schunemann, H. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American college of chest physicians task force. Chest, 2006, 129, 174–181.
Hahn, A.F., Bolton, C.F., Pillay, N., Chalk, C., Benstead, T., Bril, V., Shumak, K., Vandervoort, M.K., Feasby, T.E. Plasma exchange therapy in chronic inflammatory demyelinating polyneuropathy (CIDP): a double-blind, sham-controlled, cross-over study. Brain, 2010, 119, 1055–1066.
Kes, V.B., Zavoreo1, I., .Šerić, V., Solter, V.V., Cesarik, M., Hajnšek, S., Pašić, M.B., Gabelić, T., Bašić, S., Butković, S.S., Lušić, I., Dežmalj, L., Vladić, A., Bielen, I., Antončić, I., Demarin, V. Recommendations for diagnosis and management of multiple sclerosis. Acta Clin. Croat., 2012, 51, 117-135.
Khalife N. Immunomodulation in therapeutic plasma exchange & its clinical applications: an update on guidelines & technology. Terumo BCT, Belgium, 2013.
Mehndiratta M.M., Hughes R.A.C., Agarwal P. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. (Cochrane Review). Cochrane Database Syst. Rev., 2004, 3, CD003906.
Schwartz, J., Winters, J.L., Padmanabhan, A., Balogun, R.A., Delaney, M., Linenberger, M.L., Szczepiorkowski, Z.M., Williams, M.E., Wu, Y., Shaz, B.H. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue. Journal of Clinical Apheresis, 2013, 28, 145–284.
Sellebjerg, F., Barnes, D., Filippini, G., Midgard, R., Montalban, X., Rieckmann, P., Selmaj, K., Visser, L.H., Sørensen, P.S. EFNS Task Force on Treatment of Multiple Sclerosis Relapses. EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur. J. Neurol., 2005, 12, 12, 939-946.
Skeiea, G.O., Apostolskib, S., Evolic, A., Gilhusd, N.E., Illae, I., Harmsf, L, Hilton-Jonesg, D., Melmsh, A., Verschuureni, J., Horge, A.W. EFNS GUIDELINES. Guidelines for treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology 2010, doi:10.1111/j.1468-1331.2010.03019.x
Van den Bergh, P.Y.K., Hadden, R.D.M., Bouche, P., Cornblath, D.R., Hahn, A., Illa, I., Koski, C.L., Le´ge,r J.M., Nobile-Orazio, E., Pollard, J., Sommer, C., van Doorn, P.A., van Schaik, I.N. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First Revision. Journal of the Peripheral Nervous System, 2010, 15, 1–9.
Yoshii, F., Shinohara, Y. Autoimmune Neurological Diseases. JMAJ, 2004, 47, 9, 425-430.
Downloads
Published
How to Cite
ARK
License
Copyright (c) 2019 Bulgarian Neurology
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
